{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:32:44Z","timestamp":1787923964650,"version":"build-2784847793"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12662-5","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:01:56Z","timestamp":1787922116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating non-coding RNA profiling with HPV genotyping for cervical cancer risk stratification and early detection"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6206-6143","authenticated-orcid":false,"given":"Priyanshi","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brij","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-4174","authenticated-orcid":false,"given":"Gauri","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelima","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"1","key":"12662_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06470-x","volume":"23","author":"SK Baba","year":"2025","unstructured":"Baba SK, Alblooshi SSE, Yaqoob R, Behl S, Al Saleem M, Rakha EA, Malik F, Singh M, Macha MA, Akhtar MK, Houry WA, Bhat AA, Al Menhali A, Zheng Z-M, Mirza S (2025) Human papilloma virus (HPV) mediated cancers: an insightful update. J Transl Med 23(1):483. https:\/\/doi.org\/10.1186\/s12967-025-06470-x","journal-title":"J Transl Med"},{"key":"12662_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/578423","author":"N Pereira","year":"2015","unstructured":"Pereira N, Kucharczyk KM, Estes JL, Gerber RS, Lekovich JP, Elias RT, Spandorfer SD (2015) Human papillomavirus infection, infertility, and assisted reproductive outcomes. J Pathog. https:\/\/doi.org\/10.1155\/2015\/578423","journal-title":"J Pathog"},{"issue":"01","key":"12662_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0971-5851.96961","volume":"33","author":"K Kaarthigeyan","year":"2012","unstructured":"Kaarthigeyan K (2012) Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol 33(01):7\u201312. https:\/\/doi.org\/10.4103\/0971-5851.96961","journal-title":"Indian J Med Paediatr Oncol"},{"key":"12662_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virol.2018.01.002","volume":"516","author":"Z Chen","year":"2018","unstructured":"Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD (2018) Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516:86\u2013101. https:\/\/doi.org\/10.1016\/j.virol.2018.01.002","journal-title":"Virology"},{"key":"12662_CR5","unstructured":"World Health organization (2024) Target product profiles for human papillomavirus screening tests to detect cervical pre-cancer and cancer."},{"key":"12662_CR6","unstructured":"World Health Organization (2021) Cervical Cancer fact sheet"},{"issue":"4","key":"12662_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/14737159.2017.1293525","volume":"17","author":"A Grad\u00edssimo","year":"2017","unstructured":"Grad\u00edssimo A, Burk RD (2017) Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev Mol Diagn 17(4):379\u2013391. https:\/\/doi.org\/10.1080\/14737159.2017.1293525","journal-title":"Expert Rev Mol Diagn"},{"key":"12662_CR8","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30:F55\u2013F70. https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.083","journal-title":"Vaccine"},{"issue":"2","key":"12662_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00281-019-00773-0","volume":"42","author":"M Burley","year":"2020","unstructured":"Burley M, Roberts S, Parish JL (2020) Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle. Semin Immunopathol 42(2):159\u2013171. https:\/\/doi.org\/10.1007\/s00281-019-00773-0","journal-title":"Semin Immunopathol"},{"issue":"3","key":"12662_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/GRF.0b013e31825caa36","volume":"55","author":"JK Hathaway","year":"2012","unstructured":"Hathaway JK (2012) HPV. Clin Obstet Gynecol 55(3):671\u2013680. https:\/\/doi.org\/10.1097\/GRF.0b013e31825caa36","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"12662_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41420-019-0154-x","volume":"5","author":"P Mandal","year":"2019","unstructured":"Mandal P, Saha SS, Sen S, Bhattacharya A, Bhattacharya NP, Bucha S, Sinha M, Chowdhury RR, Mondal NR, Chakravarty B, Chatterjee T, Roy S, Chattapadhyay A, Sengupta S (2019) Cervical cancer subtypes harbouring integrated and\/or episomal HPV16 portray distinct molecular phenotypes based on transcriptome profiling of mRNAs and miRNAs. Cell Death Discov 5(1):81. https:\/\/doi.org\/10.1038\/s41420-019-0154-x","journal-title":"Cell Death Discov"},{"issue":"6","key":"12662_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1055\/s-0032-1314959","volume":"72","author":"M Jentschke","year":"2012","unstructured":"Jentschke M, Soergel P, Hillemanns P (2012) Importance of HPV genotyping for the screening, therapy and management of cervical neoplasias. Geburtshilfe Frauenheilkd 72(6):507\u2013512. https:\/\/doi.org\/10.1055\/s-0032-1314959","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"12662_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/EBC20200032","volume":"65","author":"H Yan","year":"2021","unstructured":"Yan H, Bu P (2021) Non-coding RNA in cancer. Essays Biochem 65(4):625\u2013639. https:\/\/doi.org\/10.1042\/EBC20200032","journal-title":"Essays Biochem"},{"issue":"3","key":"12662_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1042\/BST20253041","volume":"53","author":"DI Obanya","year":"2025","unstructured":"Obanya DI, Wootton LM, Morgan EL (2025) Advances in understanding the mechanisms of the human papillomavirus oncoproteins. Biochem Soc Trans 53(3):565\u2013577. https:\/\/doi.org\/10.1042\/BST20253041","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"12662_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.08.001","volume":"1872","author":"FCB Berti","year":"2019","unstructured":"Berti FCB, Salviano-Silva A, Beckert HC, de Oliveira KB, Cipolla GA, Malheiros D (2019) From squamous intraepithelial lesions to cervical cancer: circulating microRNAs as potential biomarkers in cervical carcinogenesis. Biochimica et Biophysica Acta (BBA) Reviews Cancer 1872(2):188306. https:\/\/doi.org\/10.1016\/j.bbcan.2019.08.001","journal-title":"Biochimica et Biophysica Acta (BBA) Reviews Cancer"},{"issue":"4","key":"12662_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/cimb48040414","volume":"48","author":"AK Dubey","year":"2026","unstructured":"Dubey AK, Kumar A, Nurbekova Z, Kumar N (2026) Long non-coding RNAs in human disease: an overview of biogenesis, molecular mechanism and therapeutic opportunities. Curr Issues Mol Biol 48(4):414. https:\/\/doi.org\/10.3390\/cimb48040414","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"12662_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85888-1","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, Su C, Cai Y, Ke L, Huang Y (2025) miR-21 promotes cervical cancer by regulating NTF3. Sci Rep 15(1):2442. https:\/\/doi.org\/10.1038\/s41598-025-85888-1","journal-title":"Sci Rep"},{"issue":"1","key":"12662_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15476286.2017.1391441","volume":"15","author":"HM Awan","year":"2018","unstructured":"Awan HM, Shah A, Rashid F, Wei S, Chen L, Shan G (2018) Comparing two approaches of miR-34a target identification, biotinylated-miRNA pulldown vs miRNA overexpression. RNA Biol 15(1):55\u201361. https:\/\/doi.org\/10.1080\/15476286.2017.1391441","journal-title":"RNA Biol"},{"issue":"2","key":"12662_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/ijo.2014.2758","volume":"46","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim SW, Kim YT (2015) Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol 46(2):521\u2013530. https:\/\/doi.org\/10.3892\/ijo.2014.2758","journal-title":"Int J Oncol"},{"issue":"21","key":"12662_CR20","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.7150\/jca.61194","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Zhang W, Huang W, Hua Z, Li S (2021) LncRNA MALAT1 was regulated by HPV16 E7 independently of pRB in cervical cancer cells. J Cancer 12(21):6344\u20136355. https:\/\/doi.org\/10.7150\/jca.61194","journal-title":"J Cancer"},{"key":"12662_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115527","volume":"167","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu X, Song J, Xu Y, Qian H, Jin J, Liang Z (2023) Non-coding RNAs\u2019 function in cancer development, diagnosis and therapy. Biomed Pharmacother 167:115527. https:\/\/doi.org\/10.1016\/j.biopha.2023.115527","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"12662_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen L-L, Chen R, Dean C, Dinger ME, Fitzgerald KA, Gingeras TR, Guttman M, Hirose T, Huarte M, Johnson R, Kanduri C, Kapranov P, Lawrence JB, Lee JT, Mendell JT, Mercer TR, Moore KJ, Nakagawa S, Rinn JL, Spector DL, Ulitsky I, Wan Y, Wilusz JE, Wu M (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447. https:\/\/doi.org\/10.1038\/s41580-022-00566-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12662_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-42059-2_1","author":"S Hombach","year":"2016","unstructured":"Hombach S, Kretz M (2016) Non-coding RNAs: Classification. Biol Functioning. https:\/\/doi.org\/10.1007\/978-3-319-42059-2_1","journal-title":"Biol Functioning"},{"issue":"3","key":"12662_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, Ren J (2019) Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cellular Mol Life Sci CMLS 76(3):441\u2013451. https:\/\/doi.org\/10.1007\/s00018-018-2940-7","journal-title":"Cellular Mol Life Sci CMLS"},{"issue":"7","key":"12662_CR25","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.3390\/ijms25074086","volume":"25","author":"SY Aguilar-Mart\u00ednez","year":"2024","unstructured":"Aguilar-Mart\u00ednez SY, Campos-Viguri GE, Medina-Garc\u00eda SE, Garc\u00eda-Flores RJ, Deas J, G\u00f3mez-Cer\u00f3n C, Pedroza-Torres A, Bautista-Rodr\u00edguez E, Fern\u00e1ndez-Tilapa G, Rodr\u00edguez-Dorantes M, P\u00e9rez-Plasencia C, Peralta-Zaragoza O (2024) MiR-21 Regulates growth and migration of cervical cancer cells by RECK signaling pathway. Int J Mol Sci 25(7):4086. https:\/\/doi.org\/10.3390\/ijms25074086","journal-title":"Int J Mol Sci"},{"key":"12662_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopha.2016.06.006","volume":"83","author":"H Fang","year":"2016","unstructured":"Fang H, Shuang D, Yi Z, Sheng H, Liu Y (2016) Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients. Biomed Pharmacother 83:64\u201369. https:\/\/doi.org\/10.1016\/j.biopha.2016.06.006","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"12662_CR27","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.ajpath.2011.07.037","volume":"179","author":"F Wang","year":"2011","unstructured":"Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5):2580\u20132588. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.037","journal-title":"Am J Pathol"},{"key":"12662_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-014-0228-2","volume":"9","author":"L Cai","year":"2014","unstructured":"Cai L, Cai X (2014) Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol 9:1000. https:\/\/doi.org\/10.1186\/s13000-014-0228-2","journal-title":"Diagn Pathol"},{"issue":"1","key":"12662_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03217-7","volume":"7","author":"L Anton","year":"2017","unstructured":"Anton L, DeVine A, Sierra L-J, Brown AG, Elovitz MA (2017) MiR-143 and miR-145 disrupt the cervical epithelial barrier through dysregulation of cell adhesion, apoptosis and proliferation. Sci Rep 7(1):3020. https:\/\/doi.org\/10.1038\/s41598-017-03217-7","journal-title":"Sci Rep"},{"issue":"5","key":"12662_CR30","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1007\/s13277-014-3009-3","volume":"36","author":"Q Wang","year":"2015","unstructured":"Wang Q, Qin J, Chen A, Zhou J, Liu J, Cheng J, Qiu J, Zhang J (2015) Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer. Tumor Biol 36(5):3703\u20133708. https:\/\/doi.org\/10.1007\/s13277-014-3009-3","journal-title":"Tumor Biol"},{"issue":"4","key":"12662_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10616-022-00536-0","volume":"74","author":"L Hongwei","year":"2022","unstructured":"Hongwei L, Juan L, Xiaoying X, Zhijun F (2022) MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression. Cytotechnology 74(4):469\u2013478. https:\/\/doi.org\/10.1007\/s10616-022-00536-0","journal-title":"Cytotechnology"},{"issue":"4","key":"12662_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102745","volume":"36","author":"A Alaei","year":"2025","unstructured":"Alaei A, Kakumani PK (2025) MicroRNA chemical modifications in post-transcriptional gene silencing and human diseases. Mol Therapy Nucleic Acids 36(4):102745. https:\/\/doi.org\/10.1016\/j.omtn.2025.102745","journal-title":"Mol Therapy Nucleic Acids"},{"key":"12662_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.913951","volume":"13","author":"K Otmani","year":"2022","unstructured":"Otmani K, Rouas R, Lewalle P (2022) OncomiRs as noncoding RNAs having functions in cancer: their role in immune suppression and clinical implications. Front Immunol 13:913951. https:\/\/doi.org\/10.3389\/fimmu.2022.913951","journal-title":"Front Immunol"},{"issue":"1","key":"12662_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S (2016) MicroRNA as biomarkers and diagnostics. J Cell Physiol 231(1):25\u201330. https:\/\/doi.org\/10.1002\/jcp.25056","journal-title":"J Cell Physiol"},{"issue":"3","key":"12662_CR35","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3892\/ol.2017.7638","volume":"15","author":"W Tan","year":"2018","unstructured":"Tan W, Liu B, Qu S, Liang G, Luo W, Gong C (2018) MicroRNAs and cancer: key paradigms in molecular therapy. Oncol Lett 15(3):2735\u20132742. https:\/\/doi.org\/10.3892\/ol.2017.7638","journal-title":"Oncol Lett"},{"issue":"11\u201312","key":"12662_CR36","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","volume":"1809","author":"Z-M Zheng","year":"2011","unstructured":"Zheng Z-M, Wang X (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochimica et Biophysica Acta (BBA) Gene Regulatory Mechanisms 1809(11\u201312):668\u2013677. https:\/\/doi.org\/10.1016\/j.bbagrm.2011.05.005","journal-title":"Biochimica et Biophysica Acta (BBA) Gene Regulatory Mechanisms"},{"issue":"7","key":"12662_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1080\/14737159.2017.1339603","volume":"17","author":"S Satapathy","year":"2017","unstructured":"Satapathy S, Batra J, Jeet V, Thompson EW, Punyadeera C (2017) MicroRNAs in HPV associated cancers: small players with big consequences. Expert Rev Mol Diagn 17(7):711\u2013722. https:\/\/doi.org\/10.1080\/14737159.2017.1339603","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"12662_CR38","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3892\/or.2014.3142","volume":"31","author":"H Jim\u00e9nez-Wences","year":"2014","unstructured":"Jim\u00e9nez-Wences H, Peralta-Zaragoza O, Fern\u00e1ndez-Tilapa G (2014) Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (review). Oncol Rep 31(6):2467\u20132476. https:\/\/doi.org\/10.3892\/or.2014.3142","journal-title":"Oncol Rep"},{"issue":"23","key":"12662_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312714","volume":"25","author":"A Pulliero","year":"2024","unstructured":"Pulliero A, Cassatella G, Astuni P, Khalid Z, Fiordoro S, Izzotti A (2024) The role of microRNA expression and DNA methylation in HPV-related cervical cancer: a systematic review. Int J Mol Sci 25(23):12714. https:\/\/doi.org\/10.3390\/ijms252312714","journal-title":"Int J Mol Sci"},{"issue":"21","key":"12662_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3978\/j.issn.2305-5839.2015.09.39","volume":"3","author":"J Chen","year":"2015","unstructured":"Chen J, Zhao K-N (2015) HPV-p53-miR-34a axis in HPV-associated cancers. Annals Translational Med 3(21):331. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.09.39","journal-title":"Annals Translational Med"},{"issue":"6","key":"12662_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/cncr.33221","volume":"127","author":"S Balachandra","year":"2021","unstructured":"Balachandra S, Kusin SB, Lee R, Blackwell J, Tiro JA, Cowell LG, Chiang C, Wu S, Varma S, Rivera EL, Mayo HG, Ding L, Sumer BD, Lea JS, Bagrodia A, Farkas LM, Wang R, Fakhry C, Dahlstrom KR, Sturgis EM, Day AT (2021) Blood\u2010based biomarkers of human papillomavirus\u2013associated cancers: a systematic review and meta\u2010analysis. Cancer 127(6):850\u2013864. https:\/\/doi.org\/10.1002\/cncr.33221","journal-title":"Cancer"},{"issue":"4","key":"12662_CR42","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3892\/or.2017.5905","volume":"38","author":"J Dong","year":"2017","unstructured":"Dong J, Su M, Chang W, Zhang K, Wu S, Xu T (2017) Long non-coding RNAs on the stage of cervical cancer. Oncol Rep 38(4):1923\u20131931. https:\/\/doi.org\/10.3892\/or.2017.5905","journal-title":"Oncol Rep"},{"issue":"10","key":"12662_CR43","doi-asserted-by":"publisher","first-page":"166172","DOI":"10.1016\/j.bbadis.2021.166172","volume":"1867","author":"FC Berti","year":"2021","unstructured":"Berti FC, Mathias C, Garcia LE, Gradia DF, de Araujo-Souza PS, Cipolla GA, de Oliveira JC, Malheiros D (2021) Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA. Biochimica et Biophysica Acta (BBA) Mol Basis Disease 1867(10):166172","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Disease"},{"issue":"1","key":"12662_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21032-7","volume":"12","author":"V Andric","year":"2021","unstructured":"Andric V, Nevers A, Hazra D, Auxilien S, Menant A, Graille M, Palancade B, Rougemaille M (2021) A scaffold lncRNA shapes the mitosis to meiosis switch. Nat Commun 12(1):770. https:\/\/doi.org\/10.1038\/s41467-021-21032-7","journal-title":"Nat Commun"},{"issue":"5","key":"12662_CR45","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM (2019) The role of non-coding RNAs in oncology. Cell 179(5):1033\u20131055. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017","journal-title":"Cell"},{"issue":"2","key":"12662_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","volume":"9","author":"D Xu","year":"2024","unstructured":"Xu D, Wang W, Wang D, Ding J, Zhou Y, Zhang W (2024) Long noncoding RNA MALAT-1: a versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance. Non-coding RNA Res 9(2):388\u2013406. https:\/\/doi.org\/10.1016\/j.ncrna.2024.01.015","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"12662_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06502-7","volume":"7","author":"J Zhang","year":"2017","unstructured":"Zhang J, Yao T, Lin Z, Gao Y (2017) Aberrant methylation of MEG3 functions as a potential plasma-based biomarker for cervical cancer. Sci Rep 7(1):6271. https:\/\/doi.org\/10.1038\/s41598-017-06502-7","journal-title":"Sci Rep"},{"issue":"13","key":"12662_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136502","volume":"26","author":"MdelR Lizarazo-Taborda","year":"2025","unstructured":"Lizarazo-Taborda MdelR, God\u00ednez-Rub\u00ed M, N\u00fanez-Avellaneda D, Ram\u00edrez-de-Arellano A, Pereira-Su\u00e1rez AL, Villegas-Pineda JC (2025) Cervical cancer biomarkers in non-cervical samples: emerging tools for diagnosis and prognosis. Int J Mol Sci 26(13):6502. https:\/\/doi.org\/10.3390\/ijms26136502","journal-title":"Int J Mol Sci"},{"issue":"11","key":"12662_CR49","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/14737159.2020.1835472","volume":"20","author":"MA Molina","year":"2020","unstructured":"Molina MA, Carosi Diatricch L, Castany Quintana M, Melchers WJ, Andralojc KM (2020) Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection. Expert Rev Mol Diagn 20(11):1099\u20131120. https:\/\/doi.org\/10.1080\/14737159.2020.1835472","journal-title":"Expert Rev Mol Diagn"},{"key":"12662_CR50","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171563","author":"Q Li","year":"2018","unstructured":"Li Q, Feng Y, Chao X, Shi S, Liang M, Qiao Y, Wang B, Wang P, Zhu Z (2018) HOTAIR contributes to cell proliferation and metastasis of cervical cancer via targetting miR-23b \/MAPK1 axis. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20171563"},{"issue":"26","key":"12662_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034042","volume":"102","author":"M-Y Liu","year":"2023","unstructured":"Liu M-Y, Li N (2023) The diagnostic value of lncRNA HOTAIR for cervical carcinoma in vaginal discharge and serum. Medicine (Baltimore) 102(26):e34042. https:\/\/doi.org\/10.1097\/MD.0000000000034042","journal-title":"Medicine (Baltimore)"},{"key":"12662_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00150","author":"ML Tornesello","year":"2020","unstructured":"Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL, Buonaguro FM (2020) The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00150","journal-title":"Front Oncol"},{"issue":"7","key":"12662_CR53","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/kjm2.12378","volume":"37","author":"T Song","year":"2021","unstructured":"Song T, Xu A, Chen X, Gao J, Gao F, Kong X (2021) Circular <scp>RNA<\/scp> circRNA_101996 promoted cervical cancer development by regulating <scp>miR<\/scp> -1236-3p\/ <scp>TRIM37<\/scp> axis. Kaohsiung J Med Sci 37(7):547\u2013561. https:\/\/doi.org\/10.1002\/kjm2.12378","journal-title":"Kaohsiung J Med Sci"},{"issue":"9","key":"12662_CR54","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1007\/s43032-022-00920-3","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Di Q, Chen J, Chang M, Ma Y, Yu J (2022) Circ_0000263 facilitates the proliferation and inhibits the apoptosis of cervical cancer depending on the regulation of miR-1179\/ABL2 axis. Reprod Sci 29(9):2636\u20132646. https:\/\/doi.org\/10.1007\/s43032-022-00920-3","journal-title":"Reprod Sci"},{"key":"12662_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199448","author":"K Felekkis","year":"2025","unstructured":"Felekkis K, Papaneophytou C (2025) Special issue \u2018circulating non-coding RNAs as diagnostic and prognostic markers of human diseases.\u2019 Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26199448","journal-title":"Int J Mol Sci"},{"key":"12662_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1287869","author":"AGM de Matos","year":"2024","unstructured":"de Matos AGM, Silva GEB, da Barbosa ES, de Andrade MS, Santos Lages J, da Corr\u00eaa RGCF, Oliveira AGC, Teixeira EB, da Silva MGOP, da Fonseca SSS, Teixeira-J\u00fanior AAL, Alves MS, Alencar Junior AM, Khayat AS, Pinho JD (2024) What is the role of circRNAs in the pathogenesis of cervical cancer? A systematic literature review. Frontiers Genetics. https:\/\/doi.org\/10.3389\/fgene.2024.1287869","journal-title":"Frontiers Genetics"},{"key":"12662_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1488040","author":"Y Xu","year":"2025","unstructured":"Xu Y, Li C, Cheng L, Wang S, Wu Y, Li S, Liu M, Tao X (2025) Prognostic and diagnostic value of circRNA expression in cervical cancer: a meta analysis. Frontiers Oncol. https:\/\/doi.org\/10.3389\/fonc.2024.1488040","journal-title":"Frontiers Oncol"},{"issue":"12","key":"12662_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294685","volume":"18","author":"EJ Sohn","year":"2023","unstructured":"Sohn EJ, Han M-E, Park YM, Kim YH, Oh S-O (2023) The potential of piR-823 as a diagnostic biomarker in oncology: a systematic review. PLoS ONE 18(12):e0294685. https:\/\/doi.org\/10.1371\/journal.pone.0294685","journal-title":"PLoS ONE"},{"issue":"11","key":"12662_CR59","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/14737159.2024.2408740","volume":"24","author":"MA Diamantopoulos","year":"2024","unstructured":"Diamantopoulos MA, Adamopoulos PG, Scorilas A (2024) Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update. Expert Rev Mol Diagn 24(11):979\u2013995. https:\/\/doi.org\/10.1080\/14737159.2024.2408740","journal-title":"Expert Rev Mol Diagn"},{"issue":"10","key":"12662_CR60","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3390\/diagnostics13101763","volume":"13","author":"WA Mustafa","year":"2023","unstructured":"Mustafa WA, Ismail S, Mokhtar FS, Alquran H, Al-Issa Y (2023) Cervical cancer detection techniques: a chronological review. Diagnostics (Basel) 13(10):1763. https:\/\/doi.org\/10.3390\/diagnostics13101763","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"12662_CR61","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/diagnostics12061508","volume":"12","author":"A Macios","year":"2022","unstructured":"Macios A, Nowakowski A (2022) False negative results in cervical cancer screening\u2014risks, reasons and implications for clinical practice and public health. Diagnostics (Basel) 12(6):1508. https:\/\/doi.org\/10.3390\/diagnostics12061508","journal-title":"Diagnostics (Basel)"},{"key":"12662_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4018\/978-1-6684-7136-4.ch019","volume-title":"Research anthology on medical informatics in breast and cervical cancer","author":"SK Singh","year":"2022","unstructured":"Singh SK, Goyal A (2022) Performance analysis of machine learning algorithms for cervical cancer detection. Research anthology on medical informatics in breast and cervical cancer. IGI Global, pp 347\u2013370. https:\/\/doi.org\/10.4018\/978-1-6684-7136-4.ch019"},{"issue":"2","key":"12662_CR63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4103\/0378-6323.48686","volume":"75","author":"V Mehta","year":"2009","unstructured":"Mehta V, Vasanth V, Balachandran C (2009) Pap smear. Indian J Dermatol Venereol Leprol 75(2):214\u2013216. https:\/\/doi.org\/10.4103\/0378-6323.48686","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"12662_CR64","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5114\/pjp.2023.134320","volume":"74","author":"A Marsza\u0142ek","year":"2024","unstructured":"Marsza\u0142ek A, Bakinowska J, Grobelna M, \u015aliwi\u0144ski A (2024) Assessment of the diagnostic usefulness of liquid-based cytology. The impact of modifications. Pol J Pathol 74(4):271\u2013281. https:\/\/doi.org\/10.5114\/pjp.2023.134320","journal-title":"Pol J Pathol"},{"key":"12662_CR65","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00337","author":"K Yadav","year":"2022","unstructured":"Yadav K, Cree I, Field A, Vielh P, Mehrotra R (2022) Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. JCO Global Oncol. https:\/\/doi.org\/10.1200\/GO.21.00337","journal-title":"JCO Global Oncol"},{"key":"12662_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosx.2025.100587","volume":"23","author":"UM Naikoo","year":"2025","unstructured":"Naikoo UM, Pilloton R, Farooqi H, Narang J (2025) Revolutionizing cervical cancer diagnostics: a shift from traditional techniques to biosensors. Biosens Bioelectronics: X 23:100587. https:\/\/doi.org\/10.1016\/j.biosx.2025.100587","journal-title":"Biosens Bioelectronics: X"},{"issue":"5 & 6","key":"12662_CR67","doi-asserted-by":"publisher","first-page":"509","DOI":"10.4103\/ijmr.ijmr_1143_23","volume":"158","author":"R Gupta","year":"2023","unstructured":"Gupta R, Gupta S (2023) Point-of-care tests for human papillomavirus detection in uterine cervical samples: a review of advances in resource-constrained settings. Indian J Med Res 158(5 & 6):509\u2013521. https:\/\/doi.org\/10.4103\/ijmr.ijmr_1143_23","journal-title":"Indian J Med Res"},{"key":"12662_CR68","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jcv.2015.10.008","volume":"76","author":"K Cuschieri","year":"2016","unstructured":"Cuschieri K, Bhatia R, Cruickshank M, Hillemanns P, Arbyn M (2016) HPV testing in the context of post-treatment follow up (test of cure). J Clin Virol 76:S56\u2013S61. https:\/\/doi.org\/10.1016\/j.jcv.2015.10.008","journal-title":"J Clin Virol"},{"issue":"1","key":"12662_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-025-00735-2","volume":"26","author":"PD Pratap","year":"2025","unstructured":"Pratap PD, Raza ST, Ahmad S, Rajput M (2025) From biogenesis to biomarkers: the role of piRNAs and PIWI proteins in cervical cancer and beyond. Egypt J Med Hum Genet 26(1):101. https:\/\/doi.org\/10.1186\/s43042-025-00735-2","journal-title":"Egypt J Med Hum Genet"},{"key":"12662_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncrna.2025.05.004","volume":"13","author":"G Rambaldelli","year":"2025","unstructured":"Rambaldelli G, Asghar S, Venturi G, Zacchini F, Serra M, Giovannini C, Gramantieri L, Bernini M, Inga A, Dassi E, Montanaro L (2025) Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells. Non-coding RNA Res 13:153\u2013161. https:\/\/doi.org\/10.1016\/j.ncrna.2025.05.004","journal-title":"Non-coding RNA Res"},{"issue":"2","key":"12662_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL (2015) Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 136(2):189\u2013197. https:\/\/doi.org\/10.1016\/j.ygyno.2014.11.076","journal-title":"Gynecol Oncol"},{"key":"12662_CR72","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1200\/GO.20.00024","volume":"6","author":"R Hariprasad","year":"2020","unstructured":"Hariprasad R, Tulsyan S, Babu R, Dhanasekaran K, Thakur N, Hussain S, Tripathi R, Sreenivas V, Sharma S, Sriram L, Singh S, Mehrotra R (2020) Evaluation of a chip-based, point-of-care, portable, real-time micro PCR analyzer for the detection of high-risk human papillomavirus in uterine cervix in India. JCO Glob Oncol 6:1147\u20131154. https:\/\/doi.org\/10.1200\/GO.20.00024","journal-title":"JCO Glob Oncol"},{"key":"12662_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123075","author":"M Martinelli","year":"2022","unstructured":"Martinelli M, Giubbi C, Sechi I, Bottari F, Iacobone AD, Musumeci R, Perdoni F, Muresu N, Piana A, Fruscio R, Landoni F, Cocuzza CE (2022) Evaluation of BD OnclarityTM HPV assay on self-collected vaginal and first-void urine samples as compared to clinician-collected cervical samples: a pilot study. Diagnostics (Basel, Switzerland). https:\/\/doi.org\/10.3390\/diagnostics12123075","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"2","key":"12662_CR74","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2016.27.e21","volume":"27","author":"YJ Choi","year":"2016","unstructured":"Choi YJ, Park JS (2016) Clinical significance of human papillomavirus genotyping. J Gynecol Oncol 27(2):e21. https:\/\/doi.org\/10.3802\/jgo.2016.27.e21","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"12662_CR75","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/JCM.01517-13","volume":"51","author":"DAM Heideman","year":"2013","unstructured":"Heideman DAM, Hesselink AT, van Kemenade FJ, Iftner T, Berkhof J, Topal F, Agard D, Meijer CJLM, Snijders PJF (2013) The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening. J Clin Microbiol 51(11):3653\u20133657. https:\/\/doi.org\/10.1128\/JCM.01517-13","journal-title":"J Clin Microbiol"},{"issue":"6","key":"12662_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2149","volume":"7","author":"AW Tsige","year":"2024","unstructured":"Tsige AW, Beyene DA (2024) Cervical cancer: challenges and prevention strategies: a narrative review. Health Sci Rep 7(6):e2149. https:\/\/doi.org\/10.1002\/hsr2.2149","journal-title":"Health Sci Rep"},{"issue":"7","key":"12662_CR77","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65555","volume":"16","author":"O Farajimakin","year":"2024","unstructured":"Farajimakin O (2024) Barriers to cervical cancer screening: a systematic review. Cureus 16(7):e65555. https:\/\/doi.org\/10.7759\/cureus.65555","journal-title":"Cureus"},{"key":"12662_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1170059","author":"Y Xu","year":"2023","unstructured":"Xu Y, Sun Y, Song X, Ren J (2023) The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer. Frontiers Cell Developmental Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1170059","journal-title":"Frontiers Cell Developmental Biol"},{"issue":"3","key":"12662_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e","volume":"10","author":"HT Endale","year":"2024","unstructured":"Endale HT, Mariye YF, Negash HK, Hassen FS, Asrat WB, Mengstie TA, Tesfaye W (2024) MiRNA in cervical cancer: diagnosis to therapy: systematic review. Heliyon 10(3):e24398. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e","journal-title":"Heliyon"},{"key":"12662_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1308730","author":"S Heidari-Ezzati","year":"2024","unstructured":"Heidari-Ezzati S, Moeinian P, Ahmadian-Nejad B, Maghbbouli F, Abbasi S, Zahedi M, Afkhami H, Shadab A, Sajedi N (2024) The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2024.1308730","journal-title":"Front Cell Dev Biol"},{"key":"12662_CR81","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241245939","author":"L Gao","year":"2024","unstructured":"Gao L, Fan J, He J, Che X, Wang X, Han C (2024) Small nucleolar RNAs as diagnostic and prognostic biomarkers in cancer: a systematic review and meta-analysis. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/15330338241245939","journal-title":"Technol Cancer Res Treat"},{"issue":"8","key":"12662_CR82","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.prp.2014.03.009","volume":"210","author":"LN Calil","year":"2014","unstructured":"Calil LN et al (2014) p16 INK4a and Ki67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection. Pathol Res Pract 210(8):482\u2013487","journal-title":"Pathol Res Pract"},{"issue":"1","key":"12662_CR83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ygyno.2004.11.034","volume":"97","author":"S Nieh","year":"2005","unstructured":"Nieh S, Chen S-F, Chu T-Y, Lai H-C, Lin Y-S, Fu E, Gau C-H (2005) Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 97(1):35\u201340. https:\/\/doi.org\/10.1016\/j.ygyno.2004.11.034","journal-title":"Gynecol Oncol"},{"key":"12662_CR84","doi-asserted-by":"crossref","unstructured":"Y\u0131ld\u0131z IZ, Usub\u00fct\u00fcn A, F\u0131rat P, Ayhan A, K\u00fc\u00e7\u00fckali T (2007) Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathology - Research and Practice","DOI":"10.1016\/j.prp.2007.03.010"},{"issue":"1","key":"12662_CR85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12885-019-5492-9","volume":"19","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z (2019) Performance of p16\/Ki67 immunostaining, HPV E6\/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS. BMC Cancer 19(1):271. https:\/\/doi.org\/10.1186\/s12885-019-5492-9","journal-title":"BMC Cancer"},{"issue":"1","key":"12662_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-024-01669-z","volume":"16","author":"MJ Fackler","year":"2024","unstructured":"Fackler MJ, Pleas M, Li Y, Soni A, Xing D, Cope L, Ali S, Van Le Q, Van Nguyen C, Pham HT, Duong LM, Vanden Berg E, Wadee R, Michelow P, Chen WC, Joffe M, Fjeldbo CS, Lyng H, Sukumar S (2024) Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries. Clin Epigenetics 16(1):56. https:\/\/doi.org\/10.1186\/s13148-024-01669-z","journal-title":"Clin Epigenetics"},{"issue":"3","key":"12662_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003528","volume":"18","author":"HA Kelly","year":"2021","unstructured":"Kelly HA, Chikandiwa A, Sawadogo B, Gilham C, Michelow P, Lompo OG, Omar T, Zan S, Magooa P, Segondy M, Nagot N, Meda N, Delany-Moretlwe S, Mayaud P (2021) Diagnostic accuracy of cervical cancer screening and screening\u2013triage strategies among women living with HIV-1 in Burkina Faso and South Africa: a cohort study. PLoS Med 18(3):e1003528. https:\/\/doi.org\/10.1371\/journal.pmed.1003528","journal-title":"PLoS Med"},{"key":"12662_CR88","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48343","author":"S Dasgupta","year":"2023","unstructured":"Dasgupta S (2023) The efficiency of cervical pap and comparison of conventional pap smear and liquid-based cytology: a review. Cureus. https:\/\/doi.org\/10.7759\/cureus.48343","journal-title":"Cureus"},{"key":"12662_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202200386","author":"R Raj","year":"2023","unstructured":"Raj R, Firoz Khan M, Shariq M, Ahsan N, Singh R, Kumar Basoya P (2023) Point-of-care optical devices in clinical imaging and screening: a review on the state of the art. J Biophotonics. https:\/\/doi.org\/10.1002\/jbio.202200386","journal-title":"J Biophotonics"},{"issue":"3","key":"12662_CR90","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4103\/0970-0218.158873","volume":"40","author":"UR Poli","year":"2015","unstructured":"Poli UR, Bidinger PD, Gowrishankar S (2015) Visual inspection with acetic acid (VIA) screening program: 7 years experience in early detection of cervical cancer and pre-cancers in rural South India. Indian J Community Med Official Publ Indian Association Preventive Social Med 40(3):203\u2013207. https:\/\/doi.org\/10.4103\/0970-0218.158873","journal-title":"Indian J Community Med Official Publ Indian Association Preventive Social Med"},{"issue":"12","key":"12662_CR91","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.18203\/2320-1770.ijrcog20243596","volume":"13","author":"G Lata","year":"2024","unstructured":"Lata G, Gupta L (2024) Colposcopic evaluation of unhealthy cervix and its correlation with pap smear and cervical biopsy. Int J Reprod Contracept Obstet Gynecol 13(12):3626\u20133631. https:\/\/doi.org\/10.18203\/2320-1770.ijrcog20243596","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"5","key":"12662_CR92","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1128\/jvi.78.5.2620-2626.2004","volume":"78","author":"ST Oh","year":"2004","unstructured":"Oh ST, Longworth MS, Laimins LA (2004) Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol 78(5):2620\u20132626. https:\/\/doi.org\/10.1128\/jvi.78.5.2620-2626.2004","journal-title":"J Virol"},{"issue":"11","key":"12662_CR93","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1073\/pnas.1401430111","volume":"111","author":"X Wang","year":"2014","unstructured":"Wang X, Wang H-K, Li Y, Hafner M, Banerjee NS, Tang S, Briskin D, Meyers C, Chow LT, Xie X, Tuschl T, Zheng Z-M (2014) MicroRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 111(11):4262\u20134267. https:\/\/doi.org\/10.1073\/pnas.1401430111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12662_CR94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014195118","author":"H Liu","year":"2021","unstructured":"Liu H, Xu J, Yang Y, Wang X, Wu E, Majerciak V, Zhang T, Steenbergen RDM, Wang H-K, Banerjee NS, Li Y, Lu W, Meyers C, Zhu J, Xie X, Chow LT, Zheng Z-M (2021) Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2014195118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"12662_CR95","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.7150\/jca.24253","volume":"9","author":"S-R Zheng","year":"2018","unstructured":"Zheng S-R, Zhang H-R, Zhang Z-F, Lai S-Y, Huang L-J, Liu J, Bai X, Ding K, Zhou J-Y (2018) Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells. J Cancer 9(20):3755\u20133764. https:\/\/doi.org\/10.7150\/jca.24253","journal-title":"J Cancer"},{"issue":"1","key":"12662_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4590-4","volume":"18","author":"B Pardini","year":"2018","unstructured":"Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A (2018) MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer 18(1):696. https:\/\/doi.org\/10.1186\/s12885-018-4590-4","journal-title":"BMC Cancer"},{"issue":"5","key":"12662_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5468\/ogs.21123","volume":"64","author":"K Nagandla","year":"2021","unstructured":"Nagandla K, Lin KH, Chitra E, Jamli MFBM (2021) Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review. Obstet Gynecol Sci 64(5):419\u2013436. https:\/\/doi.org\/10.5468\/ogs.21123","journal-title":"Obstet Gynecol Sci"},{"issue":"13","key":"12662_CR98","doi-asserted-by":"publisher","first-page":"11969","DOI":"10.1007\/s00432-023-05023-3","volume":"149","author":"AN Winters","year":"2023","unstructured":"Winters AN, Berry AK, Dewenter TA, Chowdhury NU, Wright KL, Cameron JE (2023) MicroRNA expression associated with low-grade cervical intraepithelial neoplasia outcomes. J Cancer Res Clin Oncol 149(13):11969\u201311978. https:\/\/doi.org\/10.1007\/s00432-023-05023-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"12662_CR99","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/br.2013.191","volume":"2","author":"J-H He","year":"2014","unstructured":"He J-H, Han Z-P, Li Y-G (2014) Association between long non-coding RNA and human rare diseases (Review). Biomed Rep 2(1):19\u201323. https:\/\/doi.org\/10.3892\/br.2013.191","journal-title":"Biomed Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12662-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12662-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12662-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:02:01Z","timestamp":1787922121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12662-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12662"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12662-5","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20171563","asserted-by":"subject"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"28 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1482"}}